165 related articles for article (PubMed ID: 33769184)
1. Xanthone glucoside 2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3β and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk.
Mangangcha IR; Brojen Singh RK; Lebeche D; Ali S
J Biomol Struct Dyn; 2022 Oct; 40(17):7868-7884. PubMed ID: 33769184
[TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
3. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
Zhu J; Wu Y; Xu L; Jin J
Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
[TBL] [Abstract][Full Text] [Related]
4. Computational prediction and experimental validation of the activator function of C2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthone on pancreatic and hepatic hexokinase.
Shinkafi TS; Kaushik A; Mahmood A; Tiwari AK; Alam MM; Akhter M; Gupta D; Ali S
J Biomol Struct Dyn; 2020 Jul; 38(10):2976-2987. PubMed ID: 31366304
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Chem Inf Model; 2011 May; 51(5):1025-36. PubMed ID: 21495724
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
[TBL] [Abstract][Full Text] [Related]
7. Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.
Zhao S; Zhu J; Xu L; Jin J
Chem Biol Drug Des; 2017 Jun; 89(6):846-855. PubMed ID: 27863047
[TBL] [Abstract][Full Text] [Related]
8. Prediction of binding affinity of 1,2-diphenyline ketone analogues at adenosine triphosphate binding site of glycogen synthase kinase-3β: a molecular docking and dynamic simulation study.
Dinakar S; Gurubarath M; Dhananjayan K
J Biomol Struct Dyn; 2023 Jul; 41(11):4847-4862. PubMed ID: 35543239
[TBL] [Abstract][Full Text] [Related]
9. Effect of double mutations K214/A-E215/Q of FRATide on GSK3β: insights from molecular dynamics simulation and normal mode analysis.
Lu SY; Jiang YJ; Zou JW; Wu TX
Amino Acids; 2012 Jul; 43(1):267-77. PubMed ID: 21912861
[TBL] [Abstract][Full Text] [Related]
10. How calcium inhibits the magnesium-dependent kinase gsk3β: a molecular simulation study.
Lu SY; Huang ZM; Huang WK; Liu XY; Chen YY; Shi T; Zhang J
Proteins; 2013 May; 81(5):740-53. PubMed ID: 23184735
[TBL] [Abstract][Full Text] [Related]
11. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
[TBL] [Abstract][Full Text] [Related]
12. Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs.
Balasubramaniam M; Mainali N; Bowroju SK; Atluri P; Penthala NR; Ayyadevera S; Crooks PA; Shmookler Reis RJ
Sci Rep; 2020 Oct; 10(1):18326. PubMed ID: 33110096
[TBL] [Abstract][Full Text] [Related]
13. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.
Lu K; Wang X; Chen Y; Liang D; Luo H; Long L; Hu Z; Bao J
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):456-464. PubMed ID: 29546355
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions.
Wang L; Zuo B; Xu D; Ren Z; Zhang H; Li X; Lei M; Xiong Y
PLoS One; 2012; 7(7):e40250. PubMed ID: 22792253
[TBL] [Abstract][Full Text] [Related]
15. Identification and Mechanistic Characterization of a Peptide Inhibitor of Glycogen Synthase Kinase (GSK3β) Derived from the Disrupted in Schizophrenia 1 (DISC1) Protein.
Saundh SL; Patnaik D; Gagné S; Bishop JA; Lipsit S; Amat S; Pujari N; Nambisan AK; Bigsby R; Murphy M; Tsai LH; Haggarty SJ; Leung AK
ACS Chem Neurosci; 2020 Dec; 11(24):4128-4138. PubMed ID: 33253521
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
17. Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
Mai W; Miyashita K; Shakoori A; Zhang B; Yu ZW; Takahashi Y; Motoo Y; Kawakami K; Minamoto T
Oncology; 2006; 71(3-4):297-305. PubMed ID: 17652946
[TBL] [Abstract][Full Text] [Related]
18. Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain.
Soutar MP; Kim WY; Williamson R; Peggie M; Hastie CJ; McLauchlan H; Snider WD; Gordon-Weeks PR; Sutherland C
J Neurochem; 2010 Nov; 115(4):974-83. PubMed ID: 20831597
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase.
Xiao JF; Li ZS; Sun M; Zhang Y; Sun CC
Comput Biol Chem; 2004 Jul; 28(3):179-88. PubMed ID: 15261148
[TBL] [Abstract][Full Text] [Related]
20. Binding and stability of indirubin-3-monoxime in the GSK3β enzyme: a molecular dynamics simulation and binding free energy study.
Saravanan K; Hunday G; Kumaradhas P
J Biomol Struct Dyn; 2020 Mar; 38(4):957-974. PubMed ID: 30963817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
